Respiratory Pathogen Panel
Respiratory Pathogen Panel
- Faster Turnaround Time
- Higher Accuracy
- Precise Treatment Recommendations
- Improves Antibiotic Stewardship
Rapid identification of respiratory pathogens and Coronavirus utilizing Quantitative Real time PCR Technology
Acute respiratory infections represent a significant cause of morbidity and mortality in young, geriatric, immunocompromised patients, or those with chronic pulmonary diseases.
Viral and bacterial infections have overlapping clinical presentations making a definitive diagnosis difficult.
Co-infections are also common and access to advanced technology is essential to precisely detect multiple pathogens at once.
False negative test results can lead to a delayed diagnosis and poor clinical outcomes
Traditional virus cultures or enzyme immunoassays lack the necessary sensitivity and accuracy. RT-PCR has emerged as a validated strategy for the rapid detection and precise identification of respiratory pathogens.
Rapid and precise pathogen identification is essential to effectively control the spread of infection.
The Respiratory Pathogen Panel quickly detects and differentiates viral and bacterial pathogens so effective treatment can begin sooner
The Respiratory Pathogen Panel utilizes quantitative Real-Time PCR to analyze your patient’s nasal sample and reports results in the same to 24 hours. The test precisely identifies 16 respiratory viruses and bacterial species, including Coronavirus from a single specimen. Same day to 24-hour turnaround time, preventing delays in diagnosis and treatment
- Identifies polymicrobial infections
- More definitive than POC antigen tests
- More accurate the culture
- Reduces false negatives
- Not affected by antibiotic use
- Antibiotic gene resistance identification
- Reduces unnecessary antibiotics
- Helps avoid unnecessary hospitalization
- Access results via web portal
cs@genetixiq.com
Phone
(703) 891-1919
Fax
(703) 891-1877